These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 18196620

  • 1. A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study).
    Zhu JR, Tomlinson B, Ro YM, Sim KH, Lee YT, Sriratanasathavorn C.
    Curr Med Res Opin; 2007 Dec; 23(12):3055-68. PubMed ID: 18196620
    [Abstract] [Full Text] [Related]

  • 2. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 3. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 4. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.
    Strutt K, Caplan R, Hutchison H, Dane A, Blasetto J.
    Circ J; 2004 Feb; 68(2):107-13. PubMed ID: 14745143
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.
    Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
    [Abstract] [Full Text] [Related]

  • 6. Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).
    Deedwania PC, Gupta M, Stein M, Ycas J, Gold A, IRIS Study Group.
    Am J Cardiol; 2007 Jun 01; 99(11):1538-43. PubMed ID: 17531577
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE.
    N Engl J Med; 2011 Dec 01; 365(22):2078-87. PubMed ID: 22085316
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group.
    Curr Med Res Opin; 2003 Dec 01; 19(8):689-98. PubMed ID: 14687438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial).
    Lloret R, Ycas J, Stein M, Haffner S, STARSHIP Study Group.
    Am J Cardiol; 2006 Sep 15; 98(6):768-73. PubMed ID: 16950182
    [Abstract] [Full Text] [Related]

  • 13. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 15; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
    Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW, STELLAR Study Group.
    Am J Cardiol; 2003 Jul 15; 92(2):152-60. PubMed ID: 12860216
    [Abstract] [Full Text] [Related]

  • 15. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
    Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.
    Am J Cardiol; 2003 Mar 06; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
    [Abstract] [Full Text] [Related]

  • 16. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.
    Olsson AG, Istad H, Luurila O, Ose L, Stender S, Tuomilehto J, Wiklund O, Southworth H, Pears J, Wilpshaar JW, Rosuvastatin Investigators Group.
    Am Heart J; 2002 Dec 06; 144(6):1044-51. PubMed ID: 12486429
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K, Izuhara M, Mitsuoka H, Uegaito T, Matsuda M, Kishiwada Atherosclerosis Prevention Study (KAPS) Group.
    Cardiovasc Ther; 2014 Jun 06; 32(3):97-104. PubMed ID: 24456217
    [Abstract] [Full Text] [Related]

  • 19. Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.
    Calza L, Manfredi R, Colangeli V, Pocaterra D, Pavoni M, Chiodo F.
    Curr HIV Res; 2008 Nov 06; 6(6):572-8. PubMed ID: 18991624
    [Abstract] [Full Text] [Related]

  • 20. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
    Wolffenbuttel BH, Franken AA, Vincent HH, Dutch Corall Study Group.
    J Intern Med; 2005 Jun 06; 257(6):531-9. PubMed ID: 15910557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.